// App-Quantinova.ai

3078 : A New Platform For Trivalent Bispecific Antibodies Used For T-Cell Redirected Killing Of B-Cell Malignancies

Researchers

Presenter

  • Diane L Rossi

Principal Investigators

  • Edmund A Rossi

  • David M Goldenberg

  • Chien-Hsing Chang

Medical Centers

  • Garden State Cancer Center, Center for Molecular Medicine and Immunology, Morris Plains, NJ

Locations

  • United States

Companies

  • IBC Pharmaceuticals,

  • Immunomedics, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mantle cell lymphoma

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Human Leukocyte Antigen – DR isotype

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved